Perpetual Ltd Cuts Stock Holdings in Stericycle, Inc. (NASDAQ:SRCL)

Perpetual Ltd lowered its position in Stericycle, Inc. (NASDAQ:SRCL) by 1.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 280,360 shares of the business services provider’s stock after selling 4,300 shares during the period. Perpetual Ltd owned about 0.30% of Stericycle worth $14,887,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. Pathstone Family Office LLC purchased a new stake in shares of Stericycle during the third quarter valued at approximately $230,000. HighTower Advisors LLC raised its stake in shares of Stericycle by 5.3% during the 3rd quarter. HighTower Advisors LLC now owns 12,001 shares of the business services provider’s stock worth $541,000 after purchasing an additional 600 shares during the period. Citigroup Inc. boosted its holdings in shares of Stericycle by 0.6% in the 3rd quarter. Citigroup Inc. now owns 46,953 shares of the business services provider’s stock worth $2,099,000 after buying an additional 285 shares during the last quarter. Envestnet Portfolio Solutions Inc. bought a new position in Stericycle during the third quarter valued at about $330,000. Finally, Envestnet Asset Management Inc. increased its holdings in Stericycle by 62.3% during the third quarter. Envestnet Asset Management Inc. now owns 329,971 shares of the business services provider’s stock worth $14,753,000 after buying an additional 126,700 shares during the last quarter. 98.82% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

SRCL has been the topic of a number of research analyst reports. Keefe, Bruyette & Woods boosted their target price on shares of Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research note on Tuesday, June 4th. Stifel Nicolaus raised their target price on Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a research report on Thursday, February 29th. Wells Fargo & Company upped their price target on Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research report on Friday, March 1st. Robert W. Baird decreased their price objective on Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a report on Friday, April 26th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $62.00 price objective (down from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $74.00.

Stericycle Price Performance

NASDAQ SRCL opened at $57.75 on Friday. The company’s 50 day simple moving average is $50.75 and its two-hundred day simple moving average is $50.40. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. Stericycle, Inc. has a 1 year low of $37.78 and a 1 year high of $59.45.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.03. The firm had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The business’s quarterly revenue was down 2.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.49 earnings per share. On average, research analysts anticipate that Stericycle, Inc. will post 2.32 earnings per share for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.